Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties

Cancer Chemotherapy and Pharmacology
Veronika JekerleMichael Wiese

Abstract

The ATP-binding cassette transporters P-glycoprotein (Pgp) and BCRP are implicated in multidrug resistance (MDR) of many tumors. Multi-targeted inhibitors such as cyclosporin A, have been shown to circumvent MDR in clinical trials. Here, we present the characterization of a novel class of effective and multi-targeted tetrahydroisoquinolin-ethyl-phenylamine based MDR inhibitors. The novel MDR inhibitors, XR9577, WK-X-34, WK-X-50 and WK-X-84 were examined for cellular toxicity in several cell lines. Chemosensitivity and inhibition of BCRP-mediated mitoxantrone efflux were analyzed in BCRP-overexpressing MCF7/mx cells. Chemosensitivity towards daunorubicin and inhibition of Pgp-mediated efflux of (99m)Tc-Sestamibi were examined in Pgp-overexpressing A2780/Adr cells. Potential MRP-interactions were evaluated with 5-CFDA efflux assays in selectively transfected MRP-1, -2 and -3 cell lines. All WK-X-compounds showed significant BCRP inhibition in the MCF7/mx cells resulting in significant increases in mitoxantrone intracellular accumulation and 200-300 fold increases in mitroxantrone cytotoxicity. WK-X-34 and XR9577 were also potent inhibitors of Pgp, increasing (99m)Tc-Sestamibi accumulation with IC(50) values in the nM range. Dauno...Continue Reading

References

Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A T FojoI Pastan
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S DaltonS E Salmon
Dec 29, 1995·The American Journal of Medicine·V Ling
Mar 31, 1999·Bioorganic & Medicinal Chemistry Letters·M RoeP Charlton
Jul 10, 1999·Journal of Neurology·J M GijtenbeekC J Vecht
Mar 17, 2000·Leukemia·D D Ross
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R Krishna, L D Mayer
Feb 13, 2001·British Journal of Cancer·T MuzzammilJ R Ballinger
Feb 28, 2001·Nature Biotechnology
Nov 8, 2001·Canadian Journal of Physiology and Pharmacology·G Lee, M Piquette-Miller
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·S E BatesT Litman
Nov 15, 2002·Cancer Biology & Therapy·Wafik S El-Deiry
Oct 25, 2003·Oncogene·Gary D Kruh, Martin G Belinsky
Apr 30, 2004·Journal of Medicinal Chemistry·Ilza K PajevaMichael Wiese
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Misbah QadirMaria R Baer
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marc H G P RaaijmakersReinier A P Raymakers
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Apr 29, 2006·International Journal of Cancer. Journal International Du Cancer·Veronika JekerleMichael Wiese
Nov 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ronan J KellySusan E Bates

❮ Previous
Next ❯

Citations

Mar 29, 2008·Expert Opinion on Drug Metabolism & Toxicology·Orsolya PolgarSusan E Bates
Feb 6, 2008·Expert Opinion on Drug Metabolism & Toxicology·Suneet ShuklaSuresh V Ambudkar
Jan 16, 2015·Journal of Inorganic Biochemistry·Veronika F S PapeGergely Szakács
Jul 22, 2015·European Journal of Medicinal Chemistry·Xu-Qin LiKenneth K W To
Sep 30, 2015·BMC Research Notes·Martin MichaelisJindrich Cinatl
Mar 21, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Iichiro KawaharaTakuya Fujita
Sep 28, 2016·Molecular Cancer Therapeutics·Jerec W RicciRichard S Larson
Aug 19, 2008·Bioorganic & Medicinal Chemistry Letters·Stefan LeyersMichael Wiese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.